MEDIFAST INC — Earnings Quality Grade B
MED · Consumer Cyclical
Generally healthy
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
Insufficient data
Insufficient data
Revenue -36.0%, CFFO -72.0%. Cash follows revenue
Expense Quality
Inventory -52.3% vs COGS -29.9%. Normal
CapEx growth -24.7% vs revenue -36.0%. Normal
SG&A/Gross Profit = 105.2%, exceeds 70%
Gross margin 71.3%, change -2.5pp. Stable
Cash Flow Quality
CFFO/NI = -0.37. Below 1.0
FCF $0.0B, FCF/NI = -0.07
Accruals ratio = -10.3%. Low accruals
Cash $0.2B covers debt $0.0B
Balance Sheet Health
No goodwill. Clean balance sheet
Debt/EBITDA = 368.8x (>4x). Financial stress
Other assets -19.0% vs revenue -36.0%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
No goodwill
Manipulation Score
Insufficient data
Portfolio monitoring
Monitor MED continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25